Valeo Financial Advisors, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 327 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2021$8,000
-55.6%
60
-42.9%
0.00%
-100.0%
Q4 2020$18,000
+125.0%
105
-26.1%
0.00%0.0%
Q2 2020$8,000
-20.0%
142
+2.2%
0.00%0.0%
Q1 2020$10,000
-16.7%
1390.0%0.00%0.0%
Q4 2019$12,000
+500.0%
139
+120.6%
0.00%
Q3 2018$2,000630.00%
Other shareholders
NOVOCURE LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders